Advanced Therapies Congress US 2025

Date: November 18th–19th, 2025

Location: Philadelphia, USA

PharSafer® is excited to join industry leaders at the forefront of cell, gene, and tissue-based innovation at the Advanced Therapies Congress US — a key event shaping the future of advanced medicinal products (ATMPs).​

Exclusive Speaker Session in Innovation Track

Presented by Dr. Graeme Ladds, CEO of PharSafer®:

“Advanced Vigilance for Advanced Therapies”

As ATMPs continue to transform treatment possibilities, they demand a new era of long-term, agile safety frameworks. In this session, we will address:

• The unique vigilance challenges of the ATMP landscape
• Designing scalable, modern safety frameworks
• Aligning long-term monitoring with regulatory success
• Collaborative approaches for cost-effective innovation

Who should attend: ATMP developers, regulatory strategists, pharmacovigilance teams, and advanced therapy innovators.

​Meet PharSafer® at Booth #309

Our expert team will be available throughout the event to discuss how PharSafer® supports advanced therapy developers with:

• Global Pharmacovigilance for Cell & Gene Therapies
• Risk Management & Regulatory Strategy
• Inspection Readiness & Global Labelling Support
• Scalable Safety Solutions for ATMP Portfolios
• Advanced Safety Automation with RAPTAR®​

Schedule a Meeting

To ensure a dedicated time with our experts, we encourage you to schedule your meeting with us in advance.

We look forward to connecting with you in Philadelphia for an inspiring and impactful event.

Note: For more information about the event, please visit: Advanced Therapies USA